|
|
|
Insider
Information: |
Tooman Craig A |
Relationship: |
President and CEO, Dir... |
City: |
San Antonio |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
160,480 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$17,653 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
160,480 |
|
|
Total
Value |
$17,653 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Enzon Pharmaceuticals Inc |
ENZN |
Exec VP Finance, CFO |
2010-06-18 |
160,480 |
2005-01-05 |
0 |
Premium* |
|
Aratana Therapeutics, Inc. |
PETX |
President and CEO, Dir... |
2019-07-18 |
0 |
2013-11-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2009-11-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
128,830 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2010-01-05 |
4 |
D |
$10.77 |
$44,771 |
D/D |
(4,157) |
123,610 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2010-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
127,767 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2010-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
26,666 |
123,610 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2010-01-17 |
4 |
D |
$10.91 |
$103,056 |
D/D |
(9,446) |
114,164 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2010-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
13,932 |
128,096 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2010-06-18 |
4 |
OE |
$8.59 |
$1,209,472 |
D/D |
140,800 |
283,580 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2010-06-18 |
4 |
S |
$11.25 |
$1,385,220 |
D/D |
(123,100) |
160,480 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec. V.P. Finance, CFO |
|
2010-04-03 |
4 |
D |
$10.48 |
$62,146 |
D/D |
(5,930) |
138,906 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec. V.P. Finance, CFO |
|
2010-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,740 |
144,836 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec. VP Finance, CFO |
|
2010-02-24 |
4 |
OE |
$5.73 |
$982,500 |
D/D |
150,000 |
278,096 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec. VP Finance, CFO |
|
2010-02-24 |
4 |
S |
$9.27 |
$1,390,635 |
D/D |
(150,000) |
128,096 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Executive Vice President |
|
2005-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
PETX |
Aratana Therapeutics, Inc... |
President and CEO |
|
2019-07-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(307,501) |
0 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
President, CEO and CFO |
|
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
211,267 |
325,991 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
President, CEO and CFO |
|
2019-01-24 |
4 |
D |
$4.22 |
$78,028 |
D/D |
(18,490) |
307,501 |
0 |
- |
|
41 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|